Sun-Ranbaxy deal gets final CCI nod; Emcure to buy 7 brands
Sun Pharma and Ranbaxy have got approval from the Competition Commission for sale of seven brands to Emcure Pharma to comply with the fair trade watchdog's conditional nod for their USD 4-billion merger.
Mar 23, 2015, 20:08 PM IST
FTC passes final order in USD 4 billion Sun-Ranbaxy deal
US anti-trust regulator FTC has passed its final order settling charges that Sun Pharma's USD 4 billion deal to acquire Ranbaxy Laboratories could result in unfair business practices.
Mar 20, 2015, 23:11 PM IST
CCI packs punch for fairness; slaps Rs 2,700 cr fine in 2014
Wielding its powers for fairness, the Competition Commission of India (CCI) clamped down on violators and slapped penalties worth about Rs 2,700 crore this year, with its ruling in the USD 4 billion Sun-Ranbaxy deal becoming a watershed moment.
Dec 23, 2014, 14:49 PM IST
Sun-Ranbaxy deal gets FIPB nod
The Sun Pharma-Ranbaxy transaction would create the country's largest pharmaceutical company.
Dec 01, 2014, 18:39 PM IST
CCI suggests changes to Sun Pharma-Ranbaxy deal
The deal, which CCI has prima-facie found to be in violation of competition norms, was inked in April this year and has been awaiting clearance from the competition watchdog since then.
Dec 01, 2014, 15:56 PM IST
Benefit of Ranbaxy deal to accrue in few years: Sun Pharma
It will take a "few years" for Sun Pharma to realise the benefits of its USD 4 billion takeover of Ranbaxy, said the company's Chairman Israel Makov.
Sep 29, 2014, 16:38 PM IST
Sun-Ranbaxy deal: CCI public scrutiny deadline ends today
The USD 4-billion deal would create the fifth largest specialty generics company in the world and the largest pharmaceutical company in India.
Sep 24, 2014, 17:10 PM IST
CCI says Sun-Ranbaxy deal may hit competition; seeks comments
In the first-ever public scrutiny of an M&A deal in India, fair trade watchdog CCI on Thursday invited comments from all stakeholders, including general public, on finer details of USD 4-billion merger of Ranbaxy Labs into rival Sun Pharmaceuticals.
Sep 04, 2014, 12:13 PM IST
Sun Pharma-Ranbaxy deal gets BSE, NSE clearance
The combination of Sun Pharma and Ranbaxy creates the fifth-largest speciality generics company in the world and the largest pharmaceutical company in India.
Jul 21, 2014, 13:33 PM IST
